Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the Athena Cohort

Jeanne Dieleman; MCJM Sturkenboom; M Jambroes; ICJ (Inge) Gyssens; GJ Weverling; JH ten Veen; G Schrey; P Reiss; SMJM (Sabine) Straus

Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the Athena Cohort

Jeanne Dieleman, MCJM Sturkenboom, M Jambroes, ICJ (Inge) Gyssens, GJ Weverling, JH ten Veen, G Schrey, P Reiss, SMJM (Sabine) Straus

Research output: Contribution to journal › Article › Academic › peer-review

43 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1493-1501
Number of pages	9
Journal	Archives of Internal Medicine
Volume	162
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2a9e18a6e103476f8612b79ea495f509,

title = "Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the Athena Cohort",

author = "Jeanne Dieleman and MCJM Sturkenboom and M Jambroes and Gyssens, {ICJ (Inge)} and GJ Weverling and {ten Veen}, JH and G Schrey and P Reiss and Straus, {SMJM (Sabine)}",

year = "2002",

language = "Undefined/Unknown",

volume = "162",

pages = "1493--1501",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the Athena Cohort

AU - Dieleman, Jeanne

AU - Sturkenboom, MCJM

AU - Jambroes, M

AU - Gyssens, ICJ (Inge)

AU - Weverling, GJ

AU - ten Veen, JH

AU - Schrey, G

AU - Reiss, P

AU - Straus, SMJM (Sabine)

PY - 2002

Y1 - 2002

M3 - Article

VL - 162

SP - 1493

EP - 1501

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

ER -